Cottliar A S, Slavutsky I R
Departamento de Genética, Instituto de Investigaciones Hematológicas, Academia Nacional de Medicina, Pacheco de Melo 3081, 1425 Buenos Aires, Argentina.
Medicina (B Aires). 2001;61(3):335-42.
Telomeres are specialized structures at the ends of eukaryotic chromosomes, composed of tandem repeats of a repetitive DNA sequence (TTAGGG)n and associated proteins. They have a number of important functions including the protection of chromosomes from end-to-end fusion and degradation. When telomeres become critically short, telomere separation in mitosis cannot be performed properly leading to metaphase telomeric associations (tas) and chromosome instability. This instability can be relevant for neoplastic transformation because it increases the probability of errors that can generate genetic changes critical in the multistep process of transformation, like gene amplification and loss of heterozygosity. The mechanisms involved in tas are unknown, but it could be because of failure in the enzymatic activity of telomerase, a ribonucleoprotein enzyme with an RNA template that directs synthesis of telomeric repeats at chromosome extremities, producing telomeric length stabilization. A progressive telomere shortening with ageing has been shown to occur both in vitro and in vivo. Recent studies have shown an association between the presence of tas and telomeric shortening, and also a correlation between telomere reduction and increased telomerase activity in both solid tumors and hematologic malignancies. The evidence that most human malignancies have telomerase activity would indicate that telomerase could be a prevalent and specific tumor marker, and thus may be a novel and excellent target for anti-cancer therapy.
端粒是真核生物染色体末端的特殊结构,由重复DNA序列(TTAGGG)n的串联重复序列和相关蛋白质组成。它们具有许多重要功能,包括保护染色体免于端对端融合和降解。当端粒变得极度短时,有丝分裂中端粒分离无法正常进行,导致中期端粒缔合(tas)和染色体不稳定。这种不稳定性可能与肿瘤转化相关,因为它增加了在多步骤转化过程中产生关键遗传变化(如基因扩增和杂合性缺失)的错误概率。tas所涉及的机制尚不清楚,但可能是由于端粒酶的酶活性失败,端粒酶是一种核糖核蛋白酶,带有RNA模板,可指导染色体末端端粒重复序列的合成,从而产生端粒长度稳定。随着衰老,端粒在体外和体内均会逐渐缩短。最近的研究表明,tas的存在与端粒缩短之间存在关联,并且在实体瘤和血液系统恶性肿瘤中,端粒缩短与端粒酶活性增加之间也存在相关性。大多数人类恶性肿瘤具有端粒酶活性的证据表明,端粒酶可能是一种普遍且特异性的肿瘤标志物,因此可能是抗癌治疗的一个新的且优秀的靶点。